trending Market Intelligence /marketintelligence/en/news-insights/trending/D22aqYdYo1kLSMjZlRoJpQ2 content esgSubNav
In This List

Madrigal Pharmaceuticals plans $100M common stock offering

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Madrigal Pharmaceuticals plans $100M common stock offering

Madrigal Pharmaceuticals Inc. is planning an underwritten public offering of $100 million worth of its common stock.

The company plans to grant the underwriters a 30-day option to buy up to an additional 15% of the shares offered.

Goldman Sachs & Co. LLC is the sole book runner of the offering.